Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00195754 · ClinicalTrials.gov registry record · Phase 3
A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 114
- Enrollment target
NCT00195754 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 114 participants.
The verdict
NCT00195754, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if long-term treatment, up to 1 year, with Depakote ER is safe in the reduction of occurrence of migraine headaches in adolescents.
Interventions
- DRUG divalproex sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2004-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00195754
The ClinicalTrials.gov registry entry for NCT00195754 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which divalproex sodium is the first listed.
NCT00195754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00195754 about?
NCT00195754 is a clinical study titled "A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.". The purpose of this study is to determine if long-term treatment, up to 1 year, with Depakote ER is safe in the reduction of occurrence of migraine headaches in adolescents.
What is the current status of trial NCT00195754?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 114 participants. The study started on 2004-07.
What interventions are being tested in trial NCT00195754?
The interventions under investigation include: divalproex sodium (DRUG).
Who is sponsoring clinical trial NCT00195754?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.